Citadel Advisors
CHE icon

Citadel Advisors’s Chemed CHE Stock Holding History

Citadel Advisors’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$559K Sell
1,200
-1,300
-52% -$547K ﹤0.01% 9585
2026
Q1 		$944K Buy
2,500
+700
+39% +$300K ﹤0.01% 7791
2025
Q4 		$770K Buy
1,800
+800
+80% +$348K ﹤0.01% 8000
2025
Q3 		$448K Hold
1,000
– – ﹤0.01% 9410
2025
Q2 		$487K Buy
+1,000
New +$570K ﹤0.01% 8692

Other funds holding CHE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Citadel Advisors's CHE Position: Q2 2026 in Review

Citadel Advisors sold out of Chemed (CHE) in Q2 2026, closing a stake of 114,119 shares — an estimated $48M sold.

Citadel Advisors first reported a position in CHE in Q2 2013 and held it in 39 quarters. The position peaked at $65.1M in Q4 2020. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Citadel Advisors reported no remaining Chemed position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 114,119 Chemed shares in Q2 2026, an estimated $48M.
  • Citadel Advisors first reported a position in Chemed in Q2 2013 and held it in 39 quarters.
  • Citadel Advisors's Chemed position peaked at $65.1M in Q4 2020.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.